{
    "eid": "2-s2.0-85083569717",
    "title": "Inhibition of topoisomerase II\u03b1 and induction of DNA damage in cholangiocarcinoma cells by altholactone and its halogenated benzoate derivatives",
    "cover-date": "2020-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Altholactone",
        "Cholangiocarcinoma",
        "Halogenated benzoate",
        "Topoisomerase II\u03b1"
    ],
    "authors": [
        "Sarunya Kitdumrongthum",
        "Somrudee Reabroi",
        "Kanoknetr Suksen",
        "Patoomratana Tuchinda",
        "Bamroong Munyoo",
        "Panupong Mahalapbutr",
        "Thanyada Rungrotmongkol",
        "Puey Ounjai",
        "Arthit Chairoungdua"
    ],
    "citedby-count": 5,
    "ref-count": 55,
    "ref-list": [
        "Cellular roles of DNA topoisomerases: a molecular perspective",
        "Human DNA topoisomerase I: relaxation, roles, and damage control",
        "DNA Topoisomerases: Type II",
        "Topoisomerase II: a specific marker for cell proliferation",
        "Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells",
        "Topoisomerase II\u03b1 expression in breast cancer: correlation with outcome variables",
        "The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer",
        "Recent developments in topoisomerase-targeted cancer chemotherapy",
        "Targeting DNA topoisomerase II in cancer chemotherapy",
        "Recent advances in the development of catalytic inhibitors of human DNA topoisomerase IIalpha as novel anticancer agents",
        "Recent developments of DNA poisons\u2013human DNA topoisomerase IIalpha inhibitors\u2013as anticancer agents",
        "Molecular mechanisms of etoposide",
        "Cytometric assessment of DNA damage induced by DNA topoisomerase inhibitors",
        "Antitopoisomerase drug action and resistance",
        "Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992",
        "Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity",
        "Structure-guided optimization of 4,6-substituted-1,3,5-triazin-2(1H)-ones as catalytic inhibitors of human DNA topoisomerase IIalpha",
        "Altholactone displays promising antimicrobial activity",
        "(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines",
        "Role of altholactone in inducing type II apoptosis signalling pathway and expression of cancer-related genes in cervical carcinoma HeLa cell line",
        "Altholactone induces reactive oxygen species-mediated apoptosis in bladder cancer T24 cells through mitochondrial dysfunction, MAPK-p38 activation and Akt suppression",
        "Altholactone Inhibits NF-kappaB and STAT3 activation and induces reactive oxygen species-mediated apoptosis in prostate cancer DU145 cells",
        "Halogenated benzoate derivatives of altholactone with improved anti-fungal activity",
        "Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines",
        "Aberrant expression of NF-kappaB in liver fluke associated cholangiocarcinoma: implications for targeted therapy",
        "Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT",
        "Inhibition of topoisomerase II alpha activity and induction of apoptosis in mammalian cells by semi-synthetic andrographolide analogues",
        "Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase",
        "The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage",
        "Molecular recognition of naphthoquinone-containing compounds against human DNA topoisomerase II\u03b1 ATPase domain: a molecular modeling study",
        "ZINC: a free tool to discover chemistry for biology",
        "Gaussian 09",
        "Butoxy mansonone G inhibits STAT3 and Akt signaling pathways in non-small cell lung cancers: combined experimental and theoretical investigations",
        "Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm",
        "Halogen atoms in the modern medicinal chemistry: hints for the drug design",
        "Cytotoxic styryl-lactones from the leaves and twigs of Polyalthia crassa",
        "Induction of apoptosis in cholangiocarcinoma by an andrographolide analogue is mediated through topoisomerase II alpha inhibition",
        "Inhibition of topoisomerase iialpha and induction of apoptosis in gastric cancer cells by 19-triisopropyl andrographolide",
        "Treatment with gefitinib or lapatinib induces drug resistance through downregulation of topoisomerase IIalpha expression",
        "Ginkgo biloba leaf extract induces DNA damage by inhibiting topoisomerase II activity in human hepatic cells",
        "G226, a new epipolythiodioxopiperazine derivative, triggers DNA damage and apoptosis in human cancer cells in vitro via ROS generation",
        "Histone H2AX phosphorylation: a marker for DNA damage",
        "Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes",
        "Salvicine functions as novel topoisomerase II poison by binding to ATP pocket",
        "Salvicine triggers DNA double-strand breaks and apoptosis by GSH-depletion-driven H2O2 generation and topoisomerase II inhibition",
        "DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells",
        "Induction of bulk and c-myc P2 promoter-specific DNA damage by an anti-topoisomerase II agent salvicine is an early event leading to apoptosis in HL-60 cells",
        "Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells",
        "26 S proteasome-mediated degradation of topoisomerase II cleavable complexes",
        "Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells",
        "Synthesis and evaluation of water-soluble etoposide esters of malic acid as prodrugs",
        "Styryl lactones and their derivatives: biological activities, mechanisms of action and potential leads for drug design",
        "Design, synthesis and in vitro evaluation against human cancer cells of 5-methyl-5-styryl-2,5-dihydrofuran-2-ones, a new series of goniothalamin analogues",
        "The effect of halogenation on blood-brain barrier permeability of a novel peptide drug",
        "Halogenation of drugs enhances membrane binding and permeation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Khon Kean University",
        "Thailand Science Research and Innovation",
        "CIF",
        "Mahidol University",
        "Thailand Research Fund",
        "CIF",
        "Thailand Science Research and Innovation"
    ]
}